Company Filing History:
Years Active: 2017-2020
Title: Innovations in Drug Delivery by Robert A Peterfreund
Introduction
Robert A Peterfreund is an accomplished inventor based in Newtonville, MA (US). He has made significant contributions to the field of drug delivery systems, holding a total of 2 patents. His work focuses on improving the precision and control of drug administration through advanced technologies.
Latest Patents
Peterfreund's latest patents include "Prediction, visualization, and control of drug delivery by multiple infusion pumps" and "Prediction, visualization, and control of drug delivery by infusion pumps." The first patent describes a method for predicting the delivery rate of multiple drugs dispensed by infusion pumps. This method involves receiving operating parameters related to the drug and carrier fluid pumps, determining the delivery rate of a drug at a delivery point, and predicting the concentration of the drug over time using a mathematical model. The second patent outlines systems for predicting a drug delivery profile, which includes a drug pump, a carrier fluid pump, and a processing device that predicts the drug delivery profile based on the mixed flow of drugs and carrier fluid.
Career Highlights
Throughout his career, Robert A Peterfreund has worked with notable organizations such as The General Hospital Corporation and Steward St. Elizabeth's Medical Center of Boston, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to drug delivery.
Collaborations
Peterfreund has collaborated with professionals like Michael Parker and Nathaniel M Sims, contributing to the advancement of drug delivery technologies through teamwork and shared expertise.
Conclusion
Robert A Peterfreund's innovative work in drug delivery systems showcases his dedication to improving healthcare through technology. His patents reflect a commitment to enhancing the precision of drug administration, ultimately benefiting patients and healthcare providers alike.